Michael Palfreyman
Director Técnico/Científico/I+D en Amorsa Therapeutics, Inc. .
Fortuna: 334 059 $ al 30/04/2024
Cargos activos de Michael Palfreyman
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | Director/Miembro de la Junta | 25/08/2011 | - |
Adelia Therapeutics, Inc.
Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA. | Director/Miembro de la Junta | - | - |
Director de Operaciones | - | - | |
Amorsa Therapeutics, Inc.
Amorsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Amorsa Therapeutics, Inc. is an American neuron pharmaceutical company. The company is based in Southborough. | Director Técnico/Científico/I+D | 01/04/2013 | - |
Historial de carrera de Michael Palfreyman
Antiguos cargos conocidos de Michael Palfreyman.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CYBIN INC. | Director Técnico/Científico/I+D | - | 05/06/2023 |
Torrey Pines Investment, Inc.
Torrey Pines Investment, Inc. Investment ManagersFinance Torrey Pines Investment, Inc (Torrey Pines Investment) is a venture capital firm is founded in 2002 by Nikolay Savchuk.The firm is headquartered San Diego, California. | Inversor de Capital Privado | - | - |
Psychiatric Genomics, Inc.
Psychiatric Genomics, Inc. Pharmaceuticals: MajorHealth Technology Psychiatric Genomics, Inc. developed innovative small molecule drugs. It identified gene expression patterns associated with psychiatric diseases. The company was incorporated on June 21, 2000 and was headquartered in Rockville, MD. | Corporate Officer/Principal | - | - |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Corporate Officer/Principal | - | - |
Marc Pharmaceuticals, Inc.
Marc Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Marc Pharmaceuticals, Inc. operates as a development stage pharmaceutical company. The company is headquartered in Stamford, CT. | Director Técnico/Científico/I+D | 26/01/2010 | - |
Formación de Michael Palfreyman.
The University of Nottingham | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Canadá | 2 |
Bélgica | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Sectorial
Health Technology | 7 |
Finance | 2 |
Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CYBIN INC. | Health Technology |
Empresas privadas | 7 |
---|---|
Marc Pharmaceuticals, Inc.
Marc Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Marc Pharmaceuticals, Inc. operates as a development stage pharmaceutical company. The company is headquartered in Stamford, CT. | Health Technology |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Health Technology |
Psychiatric Genomics, Inc.
Psychiatric Genomics, Inc. Pharmaceuticals: MajorHealth Technology Psychiatric Genomics, Inc. developed innovative small molecule drugs. It identified gene expression patterns associated with psychiatric diseases. The company was incorporated on June 21, 2000 and was headquartered in Rockville, MD. | Health Technology |
Torrey Pines Investment, Inc.
Torrey Pines Investment, Inc. Investment ManagersFinance Torrey Pines Investment, Inc (Torrey Pines Investment) is a venture capital firm is founded in 2002 by Nikolay Savchuk.The firm is headquartered San Diego, California. | Finance |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | Health Services |
Adelia Therapeutics, Inc.
Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA. | Health Technology |
Amorsa Therapeutics, Inc.
Amorsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Amorsa Therapeutics, Inc. is an American neuron pharmaceutical company. The company is based in Southborough. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Palfreyman
- Experiencia